Overview

A Study in the Treatment of Acute Mania

Status:
Terminated
Trial end date:
2005-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test the efficacy and total costs of olanzapine versus commonly used conventional antipsychotics in Sweden.
Phase:
Phase 4
Details
Lead Sponsor:
Eli Lilly and Company
Treatments:
Haloperidol
Haloperidol decanoate
Olanzapine